Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Pfaar

Showing results (11-20 of 306) with videos related to

Pageof 31
Sort By:
MMW Fortschritte Der Medizin|November 6, 2008
[Anaphylaxis--life-threatening allergic reactions]Oliver Pfaar, Ludger Klimek
Allergy|April 7, 2026
The Earlier the Merrier-But How?Thomas Eiwegger, Oliver Pfaar
Immunotherapy|April 11, 2018
Ragweed sublingual tablet immunotherapy: part I - evidence-based clinical efficacy and safetyPeter Socrates Creticos, Oliver Pfaar
Current Opinion in Allergy and Clinical Immunology|January 24, 2022
Update on the use of allergen challenge chambers in immunotherapy: clinical implicationsPetra U Zieglmayer, Oliver Pfaar
Immunotherapy|May 17, 2018
Ragweed sublingual tablet immunotherapy: part II - practical considerations and pertinent issuesOliver Pfaar, Peter Socrates Creticos
Allergo Journal International|September 18, 2018
Placebo effects in allergen immunotherapy: an experts' opinionAnthony J Frew, Oliver Pfaar
Current Opinion in Allergy and Clinical Immunology|May 1, 2014
Patient-reported outcomes and quality-of-life questionnaires in the assessment of rhinoconjunctivitis in childhoodDésirée Larenas-Linnemann, Oliver Pfaar
Current Opinion in Allergy and Clinical Immunology|April 15, 2009
Clinical outcome measures of specific immunotherapyOliver Pfaar, Clemens Anders, Ludger Klimek
Current Treatment Options in Allergy|March 24, 2015
Mite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials?Oliver Pfaar, Roy Gerth van Wijk
Expert Review of Clinical Immunology|May 19, 2016
New opportunities for allergen immunotherapy using synthetic peptide immuno-regulatory epitopes (SPIREs)Ludger Klimek, Oliver Pfaar, Margitta Worm
Pageof 31

Showing results (11-20 of 306) with videos related to

Sort By:
Pageof 31
MMW Fortschritte Der Medizin|November 6, 2008
[Anaphylaxis--life-threatening allergic reactions]Oliver Pfaar, Ludger Klimek
Allergy|April 7, 2026
The Earlier the Merrier-But How?Thomas Eiwegger, Oliver Pfaar
Immunotherapy|April 11, 2018
Ragweed sublingual tablet immunotherapy: part I - evidence-based clinical efficacy and safetyPeter Socrates Creticos, Oliver Pfaar
Current Opinion in Allergy and Clinical Immunology|January 24, 2022
Update on the use of allergen challenge chambers in immunotherapy: clinical implicationsPetra U Zieglmayer, Oliver Pfaar
Immunotherapy|May 17, 2018
Ragweed sublingual tablet immunotherapy: part II - practical considerations and pertinent issuesOliver Pfaar, Peter Socrates Creticos
Allergo Journal International|September 18, 2018
Placebo effects in allergen immunotherapy: an experts' opinionAnthony J Frew, Oliver Pfaar
Current Opinion in Allergy and Clinical Immunology|May 1, 2014
Patient-reported outcomes and quality-of-life questionnaires in the assessment of rhinoconjunctivitis in childhoodDésirée Larenas-Linnemann, Oliver Pfaar
Current Opinion in Allergy and Clinical Immunology|April 15, 2009
Clinical outcome measures of specific immunotherapyOliver Pfaar, Clemens Anders, Ludger Klimek
Current Treatment Options in Allergy|March 24, 2015
Mite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials?Oliver Pfaar, Roy Gerth van Wijk
Expert Review of Clinical Immunology|May 19, 2016
New opportunities for allergen immunotherapy using synthetic peptide immuno-regulatory epitopes (SPIREs)Ludger Klimek, Oliver Pfaar, Margitta Worm
Pageof 31